NCT00270517View on ClinicalTrials.gov

Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia

PHASE2UnknownINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

July 31, 2007

Conditions
Community Acquired Pneumonia
Interventions
DRUG

EDP-420 / Duration of Treatment - 3 days

DRUG

Telithromycin / Duration of Treatment - 7 days

Trial Locations (1)

02472

RECRUITING

Enanta Pharmaceuticals, Inc., Watertown

Sponsors
All Listed Sponsors
lead

Enanta Pharmaceuticals, Inc

INDUSTRY

NCT00270517 - Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia | Biotech Hunter | Biotech Hunter